comparemela.com

Latest Breaking News On - Therapeutics contact - Page 4 : comparemela.com

Akebia Receives European Commission Approval for Vafseo™ (vadadustat) for the Treatment of Symptomatic Anaemia Associated with Chronic Kidney Disease in Adults on Chronic Maintenance Dialysis

Akebia Receives European Commission Approval for Vafseo™ (vadadustat) for the Treatment of Symptomatic Anaemia Associated with Chronic Kidney Disease in Adults on Chronic Maintenance Dialysis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) $QNCX Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that it has retained MTS Health Partners, L.P. (MTS) as its financial ad.

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) $QNCX Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that its Board of Directors (the “Board”) unanimously approved the adopt.

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.